Agoracom Blog Home

Archive for the ‘Medical Marijuana Stocks’ Category

Enertopia Provides Burlington Lexaria JV Update

Posted by AGORACOM-JC at 8:11 AM on Wednesday, September 17th, 2014

VANCOUVER, BC / September 17, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) announces the Burlington, Ontario Application is in the Health Canada Preliminary Screening process.

The company is pleased to advise shareholders that its Joint Venture partner, Lexaria Corp (LXRP), and the Company have submitted their application for Licensed Producer in July 2014 and are in regular correspondence with Health Canada with respect to specific aspects of the licensing process, which are being handled by Ontario Operations Manager Mr. Donald Shaxon as responsible person in charge.

The Burlington Joint Venture with Lexaria Corp has applied to produce 10,000kg of Medical Marihuana per year under its Licensed Producer application. Enertopia has 51% interest in the joint venture and Lexaria Corp 49% as disclosed on April 9, 2014 in Enertopia’s press release #201424.

The Burlington JV has requested a Ready to build letter from Health Canada once the application has been accepted from Health Canada, see step 5 below.

For those not familiar with the Health Canada process for becoming a licensed producer, below are the levels to be reached through the application process. Note there are no specific process times for each step, however one could progress from preliminary screening to ready to build letter in as little as 90 to 120 days depending on the application submitted to Health Canada:

Step 1: Preliminary Screening
Step 2: Enhanced Screening
Step 3: Security Clearance
Step 4: Review
Step 5: Ready to build letter (if required by applicant)
Step 6: Pre-licence inspection
Step 7: Licensing

The Joint Venture (JV) has been active in the local community and has received very good community and media support. The JV also met with the local policing authority and upon licensing by Health Canada we have proposed that the local police could conduct security and swat team training at the facility. We are very pleased to be working closely with law enforcement and look forward to their insights in preventative and proactive security measures.

Enertopia at this time publically acknowledges its support for the Lexaria Corp policy on the responsible use of medical marijuana announced on August 28, 2014. Therefore, Enertopia is establishing a corporate policy wherein we will not knowingly sell medical cannabis containing more than 0.3% THC to any medical marijuana patient who is under the age of 21, unless it is in a form specifically approved by relevant government health agencies.

“Enertopia’s overriding responsibility is to cause no harm and keep Medical Marijuana as a safe and secure option for patients in search of natural healing options.” Stated President / CEO Robert McAllister.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential licensing and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Burlington Joint Venture will obtain a license under MMPR and or that the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Next Gen to Reschedule the Seattle GreenRush Financial Conference

Posted by AGORACOM-JC at 7:09 PM on Friday, September 5th, 2014

VANCOUVER, BRITISH COLUMBIA–(Sept. 5, 2014) – Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE:N)(PINKSHEETS:NXTTF)(FRANKFURT:M5BN) reports that due to numerous requests by both exhibitors and attendees to change the conference to a two day format, management has made a decision to postpone the Seattle GreenRush Financial Conference scheduled for September 23rd, 2014 to a later date. The company is actively seeking a suitable venue/date to accommodate these format changes. Management will issue a news release announcing all new developments for the conference at such time as they become available. In the event that the company is unable to secure a suitable venue and/or date this fall for Seattle, it will continue to focus on scheduling a full slate of conferences for the 2015 conference season including Seattle. The Company apologizes for any inconvenience this decision may have caused and asks that those who have been affected to please contact the Company at either 1-800-667-1870 or 604-685-1870.

Next Gen looks forward to expanding our presence; not only in North America, but also internationally as other countries continue to champion the legalization of Cannabis. Within North America, the company’s future conferences will be coordinated with those states that are in the process of Legislating the legalization of Cannabis.

About Next Gen

Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi‐billion dollar industry. Next Gen’s vision is to be the leading provider of venture capital, management expertise, education, brokerage and consultancy solutions and a facilitator for these explosive new industries.

Next Gen’s business model generates new industry business proposals and plans on a continuous basis. To that end, Management is currently developing two wholly owned subsidiaries, GreenRush Financial Conferences and GreenRush Analytical Laboratories. Management is negotiating with a number of companies who are interested in entering into contractual arrangements to co‐venture, co‐finance, and option‐joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi‐billion dollar industries.

For further information on the company, visit our website at www.NextGenMetalsInc.com.

On behalf of the Board of Directors

Harry Barr, President & CEO

FORWARD-LOOKING INFORMATION: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this news release.

Toll Free: 1.800. 667. 1870
Main: + 1 (604) 685. 1870
Fax: + 1 (604) 685. 8045
www.nextgenmetalsinc.com

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Supreme Updates Financing and Announces Launch of New Website

Posted by AGORACOM-JC at 9:05 AM on Thursday, September 4th, 2014

VANCOUVER, BRITISH COLUMBIA–(Sept. 4, 2014) – Supreme Pharmaceuticals Inc. (the “Company”) (CSE:SL) wishes to announce its intention to offer securities under of the previously announced non-brokered private placement (see news release dated August 15th, 2014) of up to 20 million units in the capital of the corporation (“Units”) at a price of $0.25 per Unit for aggregate gross proceeds of up to $5,000,000 (the “Financing”) to existing holders of common shares of the Corporation (“Existing Shareholders”). Any Existing Shareholder of Supreme as at September 3, 2014 will be eligible to purchase Units pursuant to the recently adopted “existing security holder” prospectus exemption in all Canadian jurisdictions other than Ontario and Newfoundland. Under the new regulation, there is no longer a need for an existing shareholder to qualify under the “accredited investor” exemption in order to participate in the Financing, however subscribers who do not receive advice regarding the suitability of their investment from a registered investment dealer may not purchase more than $15,000 of securities of Supreme under this exemption in any 12 month period.

In the event there is an over subscription of shares, the Company reserves the right to either reject subscriptions at its discretion, allocate on a pro rata basis or increase the size of the Financing. It is anticipated that the offering will be open until September 19th, 2014.

A director of the Company stated, “The amendment to the financing is an avenue that allows us to include our valued shareholders that wish to participate in our current placement. In addition, the new brand and fully integrated website bring the Company one step closer to its goal of becoming a commercial producer of medical marijuana.”

In addition, the company pleased to report that it has recently undergone a major rebranding and developed a new website infrastructure complete with online store, corporate information, news, doctor’s hub, and more. The new brand and website are anticipated to launch on Monday, September 8th, 2014 at www.supreme.ca.

FORWARD-LOOKING INFORMATION

This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the closing date of the Offering, the availability of the “existing security holder” exemption for purchases of Units under the Financing and the launch date for the new website. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com and such factors as the Company failing to close the offering, the Units not being eligible for purchase through certain exemptions from the prospectus requirement and failure to launch the website as anticipated. This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995..

Supreme Pharmaceuticals Inc.
Investor Relations
(604) 674-2191
[email protected]
www.supreme.ca

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Smoking hot marijuana stocks could give investors a buzz

Posted by AGORACOM-JC at 11:41 AM on Tuesday, September 2nd, 2014
Dilys Chan, BNN.ca staff
10:53 AM, E.T. | August 30, 2014
Canadian, Energy & Resources

It’s an exciting time for medical pot in Canada. Two new licensed medical marijuana companies started trading on Monday: OrganiGram Holdings Inc. (OGI.V 2.27 0.02 0.89%) and Bedrocan Cannabis Corp. (BED.V 1.12 0.04 3.7%). They joined Tweed Marijuana Inc. (TWD.V 2.45 -0.02 -0.81%) on the TSX Venture Exchange, bringing the total number of publicly traded marijuana stocks in Canada to three. Both of the new stocks ended the week above their opening prices.

The trend in the commodities space will continue with a fourth company, Mettrum, to hold an IPO in September. According to Khurram Malik, a research analyst at Jacob Securities, the fledgling licensed marijuana industry is at very early stages of enormous growth.

“The [companies] on the Venture exchange with licenses – they’re going to go from $0 to $10 million in revenue pretty quickly in the next year. Tweed’s a perfect example. They’ll have 12 grow rooms up and running by the end of the year,” said Malik.

“The question over the next few months is how quickly suppliers can get their act together and start getting their supply in the market. It is a bit tricky to produce marijuana at a large scale.”

Producers who can ramp up capacity, production and revenue quickly enough can tap into a target market that could potentially generate $1.8 billion in annual revenue, he said to BNN.

The cannabis plant can be a legitimate treatment option for over 100 ailments, said Malik, with pain relief being a common use. With an estimated 500,000 medical pot users in Canada and only 13 suppliers licensed by Health Canada, there is significant demand for product.

“These are very profitable investments for investors to be getting exposure to,” he said.

Investors can compare two key metrics of companies as the industry matures, Malik said. The first is cost to grow product, measured in dollar per gram. The second is how effectively the company acquires customers, a metric that will become more important as producers seek to differentiate themselves from their competition.

Ultimately, Malik thinks marijuana will be legalized, though it’s unclear when that will happen. In the meantime, a regulatory challenge for producers is that they can’t market directly to the consumers or open storefronts. Potential customers need a medical document, similar to a prescription, which then allows them to choose a supplier. But, they have to research and find the supplier on their own. The industry depends on its consumers being self-educating.

Despite that inconvenience, Malik isn’t worried about demand being low for medical pot.

“Buying from the legitimate producers is cheaper, it’s a higher quality and it’s more convenient than going to your proverbial street corner and buying it black market at twice the price.”

Source: http://www.bnn.ca/News/2014/8/30/Smoking-hot-marijuana-stocks-could-give-investors-a-buzz.aspx

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Supreme Pharmaceuticals Inc. Announces Brayden R. Sutton as Executive V.P

Posted by AGORACOM-JC at 11:16 AM on Thursday, August 28th, 2014

VANCOUVER, BRITISH COLUMBIA–(Aug. 28, 2014) – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (OTCBB:SPRWF)(CSE:SL) is pleased to announce Brayden R. Sutton as Executive Vice President.

Mr. Sutton will be responsible to oversee operations, assisting in the overall design and completion of the facilities, marketing, financing and business development.

Mr. Sutton has been involved on the research and analysis side of cannabis and cannabis related businesses for over 10 years. Brayden has a thorough understanding of the science of cannabis, the patients who use it, and close ties to the physician community.

He brings over 12 years of successful experience in the capital markets as an investor and financier since 2002 as well as extensive management and operational experience overseeing large-scale projects. He is also President and CEO of CannabisHealth.com as well as having served as the only Canadian Analyst for 420Investor.com.

David Stadnyk, President and CEO stated:

“We are very pleased Brayden is joining the Company as he will be a great addition to our management team with his thorough knowledge of the industry and deep understanding of our business”.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the up grading of the facility, the timing on completion of the MMPR License conditions and the start of production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com and such factors as the Company failing to finish the upgrading of the facility and put the same into production in accordance within the terms of the MMPR license. This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995.

Supreme Pharmaceuticals Inc.
Investor Relations
430 – 580 Hornby Street, Vancouver BC, V6C 3B6
604.674.2191
[email protected]
www.supremepharmaceuticals.com

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Lexaria Announces Responsible Marijuana Policy

Posted by AGORACOM-JC at 8:06 AM on Thursday, August 28th, 2014

KELOWNA, BC / August 28, 2014 / Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria” or “our” or “Lexaria CanPharm Corp”) announces our new corporate policies regarding the responsible use of medical marijuana.

In Canada, the MMPR legislation governed by Health Canada provides the framework by which qualified persons can access marijuana for medical purposes. Recently, the Supreme Court of British Columbia has also ruled that medical marijuana is a constitutional right for persons in need, deliverable in forms commonly referred to as “oils and edibles”. Lexaria intends to comply with the laws and regulations within every jurisdiction in which it might operate.

In addition, it is our philosophy to recognize the potential for harm within this sensitive industry and to build a set of corporate policies that go above and beyond those required by law. Lexaria is leading the industry with these policies.

Therefore, Lexaria is establishing a corporate policy wherein we will not knowingly sell medical cannabis containing more than 0.3% THC to any medical marijuana patient who is under the age of 21, unless it is in a form specifically approved by relevant government health agencies.

“Our goal is to safely help people live healthy and productive lives,” said Chris Bunka, CEO of Lexaria. “We want to be sure to do no harm and Lexaria’s policies are a big step in the right direction – ensuring members of our community are receiving the health benefits they need.”

Broadly speaking, there are two main ‘families’ of active ingredients in marijuana: THC (Tetrahydrocannabinol) which have primarily psychoactive properties accompanied by possible medicinal qualities; and CBD (Cannabidiol) which are believed to have more significant medicinal properties and do NOT generally have psychoactive properties. Introductory information about Cannabidiol can be found at Wikipedia at http://en.wikipedia.org/wiki/Cannabidiol

Our underage policy makes Lexaria’s and Lexaria CanPharm’s medical marijuana sales policies more restrictive than Canada’s alcohol consumption laws; and broadly in line with the USA’s alcohol consumption laws. We believe it would not be responsible to provide medical marijuana with THC-psychoactive properties to underage persons, so long as there is a CBD-based available alternative with medical properties that can meet a potential patient’s needs. We would welcome any development that sees the medical marijuana industry sector follow our lead on this issue and restrict the selling of marijuana containing THC to underage persons.

Many health care practitioners are reluctant to support the use of medical marijuana in underage patients, and it is our hope that our underage policy helps to address those concerns.

Also, Lexaria does not encourage nor support consuming marijuana through the act of smoking. Some research has indicated that the act of burning marijuana may negatively affect the delivery of potentially helpful CBD-based compounds, and smoking any substance is not conducive to good health practices. Lexaria’s policy, for those who require medical marijuana, is to encourage its consumption through edible and other legal forms that do not require smoking.

Lexaria encourages persons across Canada or in the USA whose philosophy regarding the responsible use of marijuana is in accordance with our own, to register at our website (www.lexariaenergy.com). Lexaria wishes to build a community of like-minded, responsible medical users of marijuana who can share their experiences and knowledge with each other for the benefit of all. Lexaria CanPharm Corp is in the development stages of a new website which will be announced when complete.

Lexaria reminds all parties that it does not currently posses a production license under Health Canada’s MMPR program, nor in any other jurisdiction, and cannot fill any medical marijuana prescription orders at this time.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.

Chris Bunka

Chairman & CEO

(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria and no assurance that the corporate policies described herein will produce any benefit for the Company or its shareholders.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

AGORACOM Welcomes Supreme Pharmaceuticals (SL: CSE) Canada’s Newest Entrant to $1.3B Medical Marijuana Industry

Posted by AGORACOM-JC at 10:53 AM on Monday, August 25th, 2014

SL: CSE

Supreme Pharmaceuticals Inc. dedicated to securing multiple producing medical marijuana facilities in Canada and applying for several MMPR commercial production licences.

South Okanagan Producing Facility

About The Facility

The Vendor currently owns its own facility in Okanagan Falls, British Columbia. The Vendor has cost effectively facilitated Personal-use Production License holders production of monthly crops of approximately 16,000 grams/month of medical marihuana in full compliance with all regulatory authorities. In the application for the MMPR, the company has applied for a significantly larger amount for commercial production.

The medical marijuana currently produced by private license holders requires a strictly controlled and augmented growing environment to consistently reach optimal plant characteristics in 90 days. The Vendor has designed and constructed 3 indoor purpose specific greenhouses, each of which are planted monthly, and harvested at 90 days.

Each greenhouse is fully climate controlled, with all key growing elements monitored and computer controlled to ensure consistent production. There are production elements, which require brief manual monitoring and intervention on a daily basis, but all key environmental functions are electronically controlled. The details of the process are highly commercially sensitive and valuable, and will not be disclosed until a full sale transaction is concluded.

The facility has been built to be fully compliant with all relevant building and safety requirements. All electrical, plumbing, security, and related plant and equipment are built to full commercial standards.

The facility has received and replied to the Department of Health Canada on its Marihuana for Medical Purposes Regulations Licence (MMPR) application, who required additional information on:

  • External and internal security measures
  • Updated site survey and aerial photographs
  • Further information on principal and proposed technical employees
  • Details on record keeping and information handling procedures

The Vendor has engaged external consultants and specialists to assist in the application process who have been able to respond and provide the requested documentation in a timely manner. While the Vendor is confident that their prior experience and expertise in the industry and the high commercial standards of the production facility will enable full compliance with Department of Health requirements for a full commercial MMPR license, there is no guarantee a MMPR license will be granted.

Management of Supreme and its operating subsidiary recently met with government officials, including the fire chief, local politicians, and community stakeholders in the township where its Southern Ontario green house facility (Facility 2) is located. The Company does not foresee any concerns in this area as construction progresses such that it may eventually receive final receipt of the MMPR license.

Gupta: ‘I am doubling down’ on medical marijuana


Dr. Sanjay Gupta, CNN Cheif Medical Correspondent. We have no affiliation with this well known medical expert, but his latest “Doubling Down” on the medical marijuana sector is worthy of your attention. Reasons such as these convince us we are doing the right thing in entering this market.

Medical marijuana and ‘the entourage effect’

12 Month Stock Chart

Enertopia Makes Steady Progress as Industry Heats Up

Posted by AGORACOM-JC at 10:33 AM on Monday, August 25th, 2014

WHITEFISH, MT / August 25, 2014 / Canada’s Marihuana for Medical Purposes Regulations (“MMPR”) program has been mired in controversy since the beginning. After switching from the Medical Marihuana Access Regulations (“MMAR”) to the MMPR program in October 1, 2013, Personal Use Production Licenses (“PUPL”) and Designated Person Production Licenses (“DPPL”) were phased out on March 31, 2014.

The transition from the MMAR to the MMPR program was designed to move marijuana production out of homes and into tightly regulated corporations. Unfortunately, these dynamics translated to an immediate increase in costs for many medical marijuana patients, which led to lawsuits against Health Canada to permit home growing until a better plan was established.

In the meantime, Health Canada has approved 13 licensed producers under the MMPR program that have already begun selling product. These sales are likely to accelerate as the new MMPR program picks up steam, with the government projecting about $1.3 billion per year in revenue by 2024, while home growing operations are likely to end in the near-term following the court resolutions.

Industry Heating Up

The large potential market for licensed producers under the MMPR program has led to tremendous investor interest in the space. With four licensed producers undergoing transactions to become publicly traded, including OrganiGram Inc. (TSX-V: OGI), Mettrum Ltd., Bedrocan Canada Inc., and PharmaCan Capital, investors will have the ability to invest directly or indirectly in seven of the 13 licensed producers.

Tweed Marijuana Inc. (TSX-V: TWD) (OTC: TWJMF) was the first publicly traded licensed producer and has already achieved a market capitalization of over $100 million, as of August 2014. Many private licensed producers have also reported rising demand from fund managers and venture capital firms looking for a piece of the action, signaling investor confidence in the MMPR’s ultimate success.

With many of these publicly traded companies already reaching $50 to $100 million valuations, investors may want to take a look at promising aspiring licensed producers that may be trading at a discount. Diversification across several companies that are approved and/or seeking approval may be the best way to reduce risk in a sector that is characterized by its high volatility.

Making Steady Progress

Enertopia Corp. (OTC: ENRT), with a market cap of only $10.6 million, is an aspiring licensed producer under Canada’s MMPR program that sets itself apart from the competition. With extensive experience under the prior MMAR program, the company has experience growing and handling medical marijuana, unlike many other newer applicants, and regulators know they can trust the firm to deliver on its promises.

CannabisFN Executive Interview | Enertopia Corp. (OTCQB: ENRT) from TDM Financial on Vimeo.

The company’s three major projects are all making steady progress. Security upgrades are being installed at the Green Canvas project in Saskatchewan; design upgrades are in the works at the GTA project in Ontario in partnership with Lexaria Corp. (OTC: LXRP); and, the World of Marijuana project is awaiting its Health Canada site visit as the government continues to work through its backlog.

The company is also actively pursuing opportunities to diversify into related areas like oils, edibles, and industrial hemp markets across North America. Management hopes that these efforts to establish multiple revenue streams will reduce risk for investors and ultimately help internally finance its growth. These efforts also set the company apart from many other pure-plays in the space.

Looking Ahead

Canada’s medical marijuana space may have had a rough start, but the MMPR program appears to be picking up steam. As Health Canada’s site visits take place, many companies are also becoming acquisition targets, as evidenced by Tweed’s acquisition of Park Lane Farms following its approval earlier this month. These dynamics could justify even higher valuations for smaller firms in the space.

Enertopia has a key advantage with its MMAR operating history and experienced management team. As it continues to progress towards licensure, investors in the marijuana space may want to take a second look, including those involved with U.S.-based companies like Medical Marijuana Inc. (OTC: MJNA) or Hemp Inc. (OTC: HEMP), given Canada’s more established federal-level programs.

For more information, see the following resources:

– Company Website – http://www.enertopia.com/

– CannabisFN Profile – http://www.cannabisfn.com/mdc/enertopia-corp/

Sign Up For Future Email Updates On Enertopia Corp.

http://www.tdmfinancial.com/emailassets/enrt/enrt_landing.php

Disclaimer: Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/

SOURCE: Emerging Growth LLC

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Next Gen Engages America’s First Lady of Cannabis Media Personality Cheryl Shuman to Launch Global Cannabis Summit with GreenRush Financial Conference in Seattle, WA on September 23, 2014

Posted by AGORACOM-JC at 1:26 PM on Thursday, August 21st, 2014

– Next Gen and GreenRush Financial Conferences announce historic international partnership with Media Personalities Cheryl Shuman, American’s First Lady of Cannabis to launch historic Cannabis Summit.

– Ms. Shuman brings with 30 years of expertise in the cannabis, celebrity and media industry and has launched over 1700 companies within the cannabis sector.

– First Cannabis entrepreneur to manage an historic $100 million hedge fund to invest in cannabis businesses.

– Her Celebrity driven “Beverly Hills Cannabis Club” Featured on AdWeek’s Magazine Cover for building the most recognized brand and the largest media platform in the cannabis industry beginning with $150,000 in seed capital in 2009 to $6.5 million in revenue in less than 18 months as the face of KUSH MAGAZINE.

– Shuman’s “mommy lobby” is known as the most powerful political force in American politics. As the Executive Director of Moms for Marijuana Shuman has over 500,000 followers and recognized by media as the “secret to legalizing marijuana”.

– Ms. Shuman launched an historic “rebranding” campaign for cannabis generating $537 million in earned media worldwide to date. Shuman brings an elite level of credibility, experience, relationships and exposure to GreenRush, having both worked with and been seen on ABC’s 20/20, Katie Couric Show, CNN, Fox Business News, The View, Good Morning America and many more.

– The conference is being held in Seattle, Washington on September 23, 2014 at the Washington State Convention Centre – Level 600

– GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (CSE-N, OTC-PK NXTTF, FSE-M5BN) and is aligned to be the Premier Purveyor of Investment Conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries

 


Click Image To View Full Size

Vancouver, British Columbia, Canada / TNW-ACCESSWIRE / August 21, 2014 / Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that it has engaged Cheryl Shuman of Echelon Cannabis to consult and co-host GreenRush Financial Conference being held in Seattle, Washington on September 23, 2014. Management of Next Gen is delighted to have the opportunity to work with Cheryl, who is commonly referred to as the “Martha Stewart of Marijuana” and who brings decades of experience working with media, celebrities, marketing and health care. She has been instrumental in the cannabis movement since 1996 working as an activist and legal cannabis patient. Since using cannabis therapy, she has survived cancer and injuries from two car crashes.

Her private medical cannabis collective, “The Beverly Hills Cannabis Club” is unlisted and membership is by referral only. Through her personal relationships and connections within Hollywood and the media, Cheryl Shuman has been named as one of the most influential women in the cannabis reform movement by international media.

Harry Barr, CEO, stated that, “We look forward to working with Cheryl Shuman to develop and brand the GreenRush Financial Conference as the best investment conference in this exciting and emerging multi-billion dollar Industry.”

Next Gen is scheduling a multi city conference schedule over the coming months and in association with Echelon is looking forward to continuing to establish its reputation as the premier investment/business conference in the Industry.

Next Gen and Cheryl Shuman would also like to formally invite interested investors, industry participants, stakeholders and exhibitors to the conference being held in Seattle, Washington on September 23, 2014.

If you are interested in being a speaker, exhibitor or sponsor for the GreenRush Financial Conferences, please contact:

Exhibitors/Sponsors

Cheryl Shuman [email protected] 310.779.4797

Ray Rich [email protected] 604.648.1401

Taylor Barr [email protected] 604.685.1870

Media

Cheryl Shuman [email protected] 310.779.4797

Andrew Brougham [email protected] 604.648.1414

Website: www.greenrushfinancialconferences.com

 


Click Image To View Full Size

About Next Gen

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry. Next Gen’s vision is to be the leading provider of venture capital, management expertise, education, brokerage and consultancy solutions and a facilitator for these explosive new industries.

Next Gen’s business model generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangements to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industries.

For further information on the company, visit our website at www.NextGenmetalsinc.com.

About Cheryl Shuman

Cheryl Shuman‘s TV reality started at age three with Charles Kuralt. By age 17 she’d been in several television appearances and was offered to host a twice-weekly regular show on WLWT-TV in Cincinnati that led to a segment on ‘PM Magazine.’ At age 23, Cheryl relocated to Los Angeles as the personal optician to the stars and created a new business Starry Eyes. In Hollywood with Starry Eyes, she worked on the biggest films, TV and music properties generating revenues of $22 million within 36 months. This led to her own show on the QVC Network and a mutually rewarding 7-year relationship expanding to include product placement, production and branded entertainment divisions. In 2006 Shuman was diagnosed with cancer, and after years of following failed allopathic medicine treatments, she opted for medical cannabis (raw juice and oils grown on a California farm) as an alternative. Having successfully used medical cannabis, she subsequently founded the Beverly Hills Cannabis Club, became the face of medical cannabis and is most visible woman in the medical marijuana reform movement. Cheryl received the 2013 Activist of the Year award. Together Cheryl and Aimee, her daughter and EVP of Cheryl Shuman, Inc., have reached over 100 million viewers while appearing on such mainstream shows as CNN’s Piers Morgan Live, the Katie Couric Show, The View, ABC’s 20/20, Good Morning America, Fox Business News and many other international media outlets. Cheryl Shuman is represented by agent Mark Itkin with the prestigious William Morris Endeavor Agency in Beverly Hills. For more information visit http://www.cherylshuman.com or, to contact Cheryl Shuman directly, call 310.779.4797.

On behalf of the Board of Directors

“Harry Barr”

Harry Barr

President & CEO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this News Release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Medical pot cookie prohibition ruled unconstitutional

Posted by AGORACOM-JC at 10:31 AM on Friday, August 15th, 2014

Court challenge stems from B.C. case of Owen Smith, who was charged with trafficking for baking pot cookies

CBC News Posted: Aug 14, 2014 10:42 AM PT Last Updated: Aug 15, 2014 6:35 AM PT

Ban on medical marijuana cookies ruled unconstitutional 1:57

It’s unconstitutional to forbid licensed medical marijuana users from possessing pot-laced products, such as cookies or body creams, a B.C. Court of Appeal judge has ruled.

Parliament has been given one year to recraft regulations to allow medicinal marijuana users to use products made from cannabis extract. They can include creams, salves, oils, brownies, cakes, cookies and chocolate bars.

Health Canada currently allows people suffering from debilitating illnesses access to medicinal marijuana, but only in the form of dried marijuana.

In her written reasons, Justice Risa Levine said this specification “is arbitrary and cannot be justified in a free and democratic society.”

Levine went on to state that when patients choose to use edible forms of marijuana, it “was a matter of necessity, or put another way, the restriction to dried marijuana interfered with their physical or psychological integrity.”

Pot activists react to ruling RAW2:25

Case of the pot cookie baker

The court challenge stems from the case of Owen Smith, who was charged with trafficking for baking pot cookies and producing topical cannabis creams for a medical marijuana club in Victoria in 2009.

Smith was caught baking more than 200 pot cookies for the Victoria Cannabis Buyers Club, and had a supply of cannabis-infused cooking oils and some dried dope in his apartment when he was arrested.

Marijuana ruling - Owen Smith pot cookie bakerOwen Smith was caught baking more than 200 pot cookies for the Victoria Cannabis Buyers Club in 2009. (CHEK)

He was acquitted in April 2012 after the B.C. Supreme Court ruled the medical marijuana regulations were unconstitutional, because patients were denied access to edible pot products and derivatives.

Justice Robert Johnston concluded that permitting dried cannabis alone was arbitrary and did little to further a legitimate state interest.

Thursday’s ruling means Smith acquittal stands and he will not be retried.

Health Minister Rona Ambrose’s office said in a statement released Thursday that it is “reviewing the decision in detail and considering our options.”

Marijuana laws under the microscope

Canada currently prohibits the possession and trafficking of all marijuana products under subsection 4(1) and Schedule II of the Controlled Drugs and Substances Act. However, subsection 55(1) of this act allows for exemptions to be made.

As such, an annex to that act, the Marihuana for Medical Purposes Regulations, allow people with medical need and authorization access to medicinal marijuana.

Under these regulations, many people suffering from debilitating illnesses get marijuana through Health Canada approved companies or get permission to grow it themselves.

However, the MMPR and its predecessor, the MMAR program, limit this access to dried marijuana and do not make any other exceptions to the list of banned substances detailed in Schedule II of the Controlled Drugs and Substances Act.

These banned substances, aside from the exempted dried marijuana, include cannabis resin and various extracts and derivatives of the cannabis plant.

Ottawa had hoped the B.C. Court of Appeal would strike down the B.C. Supreme Court decision.

But under Thursday’s ruling, government has been asked to review these rules, which could mean medical marijuana users would be supplied with resin or extract or be permitted to make themselves products such as pot cookies using marijuana extracts.

RULING | Full B.C. Court of Appeal ruling on medical marijuana extract case

Source: http://www.cbc.ca/news/canada/british-columbia/medical-pot-cookie-prohibition-ruled-unconstitutional-1.2736526

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks